Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Reunion Neuroscience Inc T.REUN

Healthcare Biotechnology
Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a... see more

Recent & Breaking News (TSX:REUN)

Psychedelic Companies Launch Digital Therapeutics Platforms To Accelerate And Improve Medicinal Psychedelic Research

Livemoney January 6, 2021

Field Trip Health Ltd. Announces Closing of Bought Deal Financing

GlobeNewswire January 5, 2021

Psilocybin Could be Key to Helping Millions of People with Eating Disorders

Livemoney December 31, 2020

The StockTalk Cannabis Report: Dec. 11, 2020

Dave Jackson December 11, 2020

Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs

Livemoney December 11, 2020

IIROC Trade Resumption - FTRP

Canada NewsWire December 10, 2020

Field Trip Health Ltd. Announces Increase to Bought Deal Financing to $17.4 Million

Canada NewsWire December 10, 2020

Field Trip Health Ltd. Announces $15 Million Bought Deal Offering of Units

Canada NewsWire December 9, 2020

IIROC Trading Halt - FTRP

Canada NewsWire December 9, 2020

This Fresh Psychedelic Stock Just Got Better

Stockhouse Editorial December 7, 2020

Billionaire Investors Are Investing Heavily in the Psychedelics Boom

Livemoney December 7, 2020

The StockTalk Cannabis Report: Dec. 4, 2020

Dave Jackson December 4, 2020

Field Trip Boosts Access to Psychedelic Therapies & Investing Options

Stockhouse Editorial December 3, 2020

Field Trip Health Ltd. Provides Operational and Investor Update, Announces Expanded Hours at its Field Trip Health Center in Toronto plus Rollout of Portal, Field Trip's Proprietary Digital Mental Health Platform

GlobeNewswire December 3, 2020

Psychedelic Drugs, Like MDMA Are Showing Signs of Helping with Mental Health Issues

Livemoney December 2, 2020

Field Trip Reports Q2 2021 Financial Results

Stockhouse Editorial December 1, 2020

Field Trip Health Ltd. Reports Second Fiscal Quarter 2021 Financial Results, Announces Two New Field Trip Health Center Locations

GlobeNewswire November 30, 2020

Ancient Aztec Medicine Could Be A Gamechanger For Mental Health

Livemoney November 30, 2020

Field Trip Health Ltd. Schedules Second Fiscal Quarter 2021 Financial Results Conference Call for Tuesday, December 1, 2020 at 8:00 am ET

GlobeNewswire November 25, 2020

Field Trip Enters Partnership to Measure Psychedelic Therapies on Physiology & Mental Health

Stockhouse Editorial November 19, 2020